Results 271 to 280 of about 304,614 (388)

Carbazolothiophene-2-carboxylic acid derivatives as endothelin receptor antagonists [PDF]

, 2004
G. Suresh Babu, Hui‐Ming Yu, Shyh‐Ming Yang, Jim‐Min Fang   +3 more
openalex   +1 more source

THE USE OF THE ENDOTHELIN RECEPTOR ANTAGONIST, TEZOSENTAN, BEFORE OR AFTER RENAL ISCHEMIA PROTECTS RENAL FUNCTION1

, 2001
S M Wilhelm, Nicholas T. Stowe, Ann Robinson, James A. Schulak   +3 more
openalex   +1 more source

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

Diabetologia, 2009
A. Watson, Jiaze Li, Courtney Schumacher, M. Gasparo, B. Feng, Merlin C. Thomas, T. Allen, Mark Cooper, K. Jandeleit-Dahm   +8 more
semanticscholar   +1 more source

The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2018
Kuang HY, Wu YH, Yi QJ, Tian J, Wu C, Shou WN, Lu TW.   +6 more
europepmc   +1 more source

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

The Journal of Dermatology, Volume 52, Issue 6, Page e430-e480, June 2025.
Yoshihide Asano, Jun Asai, Takayuki Ishii, Yohei Iwata, Masanari Kodera, Chie Miyabe, Akihiko Uchiyama, Youichi Ogawa, Ken Okamura, Mari Kishibe, Yuta Koike, Yorihisa Kotobuki, Noriki Fujimoto, Takuya Miyagi, Yukie Yamaguchi, Ayumi Yoshizaki, Reiko Omori, Takeshi Nakanishi, Hiroshi Fujiwara, Takeo Maekawa, Sei‐ichiro Motegi, Yuichiro Yoshino, Minoru Hasegawa, Manabu Fujimoto, Takao Tachibana, Wound, Pressure Ulcer, and Burn Guidelines Drafting Committee (connective tissue disease/vasculitis group)   +27 more
wiley   +1 more source

The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation. [PDF]

Oxid Med Cell Longev, 2018
Steven S, Oelze M, Hausding M, Roohani S, Kashani F, Kröller-Schön S, Helmstädter J, Jansen T, Baum C, Iglarz M, Schulz E, Münzel T, Daiber A.   +12 more
europepmc   +1 more source

Nonselective Endothelin Receptor Antagonist Initiated Soon After the Onset of Myocardial Infarction May Deteriorate 24-Hour Survival

, 2001
Chikako Takahashi, Yutaka Kagaya, Shigeto Namiuchi, Morihiko Takeda, Mitsumasa Fukuchi, Hiroki Otani, Mototsugu Ninomiya, Yuriko Yamane, Masahiro Kohzuki, Jun Watanabe, Kunio Shirato   +10 more
openalex   +1 more source

Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?

European Respiratory Journal, 2009
M. Hoeper
semanticscholar   +1 more source

Entry-Into-Humans Study with Tezosentan, an Intravenous Dual Endothelin Receptor Antagonist

, 2002
Jasper Dingemanse, Martine Clozel, Paul L. M. van Giersbergen   +2 more
openalex   +1 more source

1436: Bosentan, an Endothelin Dual Receptor Antagonist, Potentiates Nitric Oxide-Mediated Erectile Response in an Aging Brown-Norway Rat Model [PDF]

, 2004
Steven White, Michael Albo, Mahadevan Rajasekaran   +2 more
openalex   +1 more source